how can a mouse-derived antibody be humanized
A mouse-derived antibody can be humanized through a process called antibody engineering. This process involves modifying the mouse antibody to make it more similar to a human antibody while retaining its binding specificity and affinity.
Here are the steps involved in humanizing a mouse-derived antibody:
-
Sequencing: The DNA sequence encoding the mouse antibody is determined. This sequence contains the information for the variable regions, which are responsible for binding to the target antigen.
-
Comparison: The mouse antibody sequence is compared to the human antibody sequence to identify the differences. The goal is to retain the binding specificity of the mouse antibody while minimizing the non-human regions.
-
Framework grafting: The framework regions of the mouse antibody are replaced with the corresponding human framework regions. These regions provide the structural framework for the antibody and are less critical for antigen binding.
-
CDR grafting: The complementarity-determining regions (CDRs) of the mouse antibody, which directly interact with the target antigen, are retained. These regions are responsible for the antibody's binding specificity. The CDRs are grafted onto the human framework regions.
-
Optimization: Further modifications may be made to optimize the humanized antibody, such as adjusting the amino acid residues surrounding the CDRs to improve binding affinity or stability.
-
Expression and production: The humanized antibody sequence is cloned into an expression vector and introduced into a suitable host system, such as mammalian cells or bacteria, to produce the antibody.
-
Characterization: The humanized antibody is characterized to confirm its binding specificity, affinity, and functionality. This can be done through various assays, such as enzyme-linked immunosorbent assay (ELISA) or flow cytometry.
Humanizing a mouse-derived antibody allows for its potential therapeutic use in humans, as it reduces the risk of immunogenicity and enhances its compatibility with the human immune system.
原文地址: https://www.cveoy.top/t/topic/iyln 著作权归作者所有。请勿转载和采集!